Mostrar el registro sencillo del ítem

Artículo

dc.creatorMejías Trueba, Martaes
dc.creatorRodríguez-Pérez, Aitanaes
dc.creatorGarcía Cabrera, Emilioes
dc.creatorJiménez-Juan, Carloses
dc.creatorSánchez Fidalgo, Susanaes
dc.date.accessioned2024-02-13T14:35:09Z
dc.date.available2024-02-13T14:35:09Z
dc.date.issued2023-06-29
dc.identifier.citationMejías-Trueba, M., Rodríguez-Pérez, A., García Cabrera, E., Jiménez-Juan, C. y Sánchez Fidalgo, S. (2023). The Barriers to Deprescription in Older Patients: A Survey of Spanish Clinicians. Healthcare, 11 (13), 1879. https://doi.org/10.3390/healthcare11131879.
dc.identifier.issn2227-9032es
dc.identifier.urihttps://hdl.handle.net/11441/155193
dc.description.abstractBackground and objective: There are barriers to deprescription that hinder its implementation in clinical practice. The objective of this study was to analyse the main barriers and limitations of the deprescription process perceived by physicians who care for multipathological patients. Materials and methods: The “deprescription questionnaire of elderly patients” was adapted to an online format and sent to physicians in geriatrics. Question 1 is a reference to establish agreement or disagreement with this practice. The influence of different aspects of deprescription was analysed via the demographic characteristics of the clinicians and perceptions of the various barriers (questions 2–9) by means of bivariate analysis. Based on the latter, a multivariate model was carried out to demonstrate the relationship between barriers and the degree of deprescription agreement among respondents. Results: Of the 72 respondents, 72.2% were in favour of deprescribing. Regarding the analyses, the demographic characteristics did not influence rankings. The deprescription of preventive drugs and consensus with patients were associated with a positive attitude towards deprescribing, while withdrawing drugs prescribed by other professionals, time constraints and patient reluctance emerged as possible barriers. The only factor independently associated with deprescribing was lack of time. Conclusions: Time was found to be the main barrier to deprescription. Training, the creation of multidisciplinary teams and integrated health systems are key facilitators.es
dc.formatapplication/pdfes
dc.format.extent8 p.es
dc.language.isoenges
dc.publisherMDPIes
dc.relation.ispartofHealthcare, 11 (13), 1879.
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectDeprescriptiones
dc.subjectQuestionnairees
dc.subjectClinicianses
dc.subjectBarrierses
dc.titleThe Barriers to Deprescription in Older Patients: A Survey of Spanish Clinicianses
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicina Preventiva y Salud Públicaes
dc.relation.projectIDCM21/00115es
dc.relation.publisherversionhttps://www.mdpi.com/2227-9032/11/13/1879es
dc.identifier.doi10.3390/healthcare11131879es
dc.journaltitleHealthcarees
dc.publication.volumen11es
dc.publication.issue13es
dc.publication.initialPage1879es
dc.contributor.funderInstituto de Salud Carlos IIIes

FicherosTamañoFormatoVerDescripción
The Barriers...pdf251.6KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución 4.0 Internacional